VivoSense develops novel digital biomarkers from wearable sensor data.  VivoSense’s informatics platform for data analysis from wearable and connected technologies enables development of validated digital clinical outcome assessments (COAs) for life science research. The platform will respond to constraints in cancer research and care by delivering real-world digital clinical measures from wearable sensors, helping to advance patient focused drug development and precision medicine for cancer patients.

The company is headquartered in Newport Beach, California.